Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;396(6):1143-1153.
doi: 10.1007/s00210-023-02388-7. Epub 2023 Jan 19.

Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance

Souad Moudallel  1   2 , Celien van den Eynde  3 , Josef Malý  4 , Silas Rydant  3   5 , Stephane Steurbaut  3   6
Affiliations

Retrospective analysis of gastrointestinal bleedings with direct oral anticoagulants reported to EudraVigilance

Souad Moudallel et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Jun.

Abstract

Direct oral anticoagulants (DOACs) are increasingly used and are an important cornerstone in antithrombotic therapy. Adverse drug reactions (ADRs) such as bleedings have only partially been investigated during clinical trials. The primary goal was to analyse pharmacovigilance data based on spontaneous reports of gastrointestinal (GI) bleedings with DOACs reported to EudraVigilance. A second goal was to compare GI safety profiles between DOACs based on these signals. All DOAC related GI bleedings mentioned in individual case safety reports (ICSRs) from 2012 till 2017 in the European Economic Area were classified in four GI categories based on the reported site of occurrence of the haemorrhage. Age group and gender of the patient, seriousness and ADR outcome, and the reporter's qualification were assessed per category and per DOAC. Disproportionality analyses were performed to evaluate whether or not the reported ADRs were more prevalent with a given DOAC. ICSRs were bleeding-related in about half of the cases (n = 28,992/53,471). Of these bleedings, >25% was GI-related. Most patients experiencing GI bleedings were between 65 and 85 years old, with no obvious differences between men and women. Stomach, ulcer-related duodenal, and rectal bleedings were the most reported GI bleedings with a fatal outcome in 5.8%, 7.5%, and 9.8% of the cases for rivaroxaban, apixaban, and dabigatran, respectively. The disproportionality data suggest that dabigatran is more frequently involved in GI bleeding events than the other DOACs. DOACs were significantly associated with GI bleedings. Although the data should be interpreted with caution, it seems that dabigatran was associated more often than other DOACs with GI bleedings based on the analysis of spontaneous pharmacovigilance reports.

Keywords: Adverse drug reactions (ADRs); Direct oral anticoagulants (DOACs); EudraVigilance; Gastrointestinal bleedings; Pharmacovigilance.

PubMed Disclaimer

References

    1. Abraham NS, Noseworthy PA, Yao X, Sangaralingham LR, Shah ND (2017) Gastrointestinal safety of direct oral anticoagulants: a large population-based study. Gastroenterology 152(5):1014-1022.e1. https://doi.org/10.1053/j.gastro.2016.12.018 - DOI - PubMed
    1. Aloysius MM, Perisetti A, Goyal H et al (2021) Direct-acting oral anticoagulants versus warfarin in relation to risk of gastrointestinal bleeding: a systematic review and meta-analysis of randomized controlled trials. Ann Gastroenterol 34(5):651–659. https://doi.org/10.20524/aog.2021.0658
    1. Barnes GD, Lucas E, Alexander GC, Goldberger ZD (2015) National trends in ambulatory oral anticoagulant use. Am J Med 128(12):1300–5.e2. https://doi.org/10.1016/j.amjmed.2015.05.044 - DOI - PubMed - PMC
    1. Barnes GD, Ageno W, Ansell J, Kaatz S (2015) Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH. J Thromb Haemost 13(6):1154–6. https://doi.org/10.1111/jth.12969
    1. Chang HY, Zhou M, Tang W, Alexander GC, Singh S (2015) Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study. BMJ 350:h1585. https://doi.org/10.1136/bmj.h1585

LinkOut - more resources